May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Mechanisms of Embryonic and Fetal Human Choroidal Vascular Development
Author Affiliations & Notes
  • T. Hasegawa
    Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD
  • D.S. McLeod
    Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD
  • I. Bhutto
    Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD
  • T. Prow
    Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD
  • C. Merges
    Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD
  • R. Grebe
    Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD
  • G.A. Lutty
    Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD
  • Footnotes
    Commercial Relationships  T. Hasegawa, None; D.S. McLeod, None; I. Bhutto, None; T. Prow, None; C. Merges, None; R. Grebe, None; G.A. Lutty, None.
  • Footnotes
    Support  NIH Grants EY09357 and EY01765, Bausch Lomb Japan, Himmelfarb Foundation, RPB
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 2598. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T. Hasegawa, D.S. McLeod, I. Bhutto, T. Prow, C. Merges, R. Grebe, G.A. Lutty; Mechanisms of Embryonic and Fetal Human Choroidal Vascular Development . Invest. Ophthalmol. Vis. Sci. 2006;47(13):2598.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Little is known about normal choroidal vascular development in the embryonic and fetal human eye. Vasculogenesis and/or angiogenesis are conventionally thought to be the principle modes for new vessel formation. Hemovasculogenesis is the formation of endothelial cells accompanied by the simultaneous generation of red blood cells (erythroblasts) in blood islands of the embryo. The purpose of this study is to investigate the mechanism(s) of normal human choroidal vascular development.

Methods: : Serial cryosections of human choroids of 6–23 weeks gestation (WG) were examined immunohistochemically. Antibodies used were markers of endothelial cells (CD34, CD31), angioblasts and endothelial cells (CD39), erythroblasts [Epsilon Hemoglobin (E–Hb)], hematopoietic cells (CD45, HLA–DR), proliferating cells (Ki67), VEGF–A, and its receptors (VEGFR–1, VEGFR–2). Immunofluorescence was used for double labeling to identify the characteristics of the cell types involved. Additionally, human choroids of 6–12 WG were embedded in JB–4 for Wright’s Giemsa staining.

Results: : At 6–7 WG, many erythroblasts (nucleated RBCs by Giemsa staining) were observed in the choriocapillaris layer. Some erythroblasts were separated from and independent of any vascular structure. Many erythroblasts (E–Hb+) were also positive for CD34, CD31 and/or VEGFR–2. Few E–Hb+ cells were positive for Ki67. At this stage, few definitive vascular lumens were detected. VEGF immunoreactivity increased between 6WG and 7WG. By 8–12 WG, most of E–Hb+ cells had disappeared and vascular lumens became apparent. At 14–23 WG, no E–Hb+ cells were seen. Some Ki67 positive cells were also positive for CD34 and/or CD39, especially at the scleral side of choroicapillaris where they were associated with forming deeper choroidal vessels. Immunoreactivity of VEGFR–1 was associated with large choroidal vessels and increased after 14WG.

Conclusions: : Choroidal vascular development in the embryo and fetus appears to occur in successive stages. Embryonically, the choriocapillaris appears to initially form by hemovasculogenesis (E–Hb+/CD31+ cells), while angiogenesis appears to be the mode of large choroidal vessel development (CD34+/Ki67+).

Keywords: choroid • development • vascular cells 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×